Filing Details

Accession Number:
0001140361-15-042381
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-19 18:09:27
Reporting Period:
2015-11-17
Filing Date:
2015-11-19
Accepted Time:
2015-11-19 18:09:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1337013 Infusystem Holdings Inc INFU Surgical & Medical Instruments & Apparatus (3841) 203341405
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1572871 K Eric Steen C/O Infusystem Holdings, Inc.
31700 Research Park Drive
Madison Heights MI 48071
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-17 1,400 $2.91 156,156 No 4 P Direct
Common Stock Acquisiton 2015-11-18 100 $2.84 156,256 No 4 P Direct
Common Stock Acquisiton 2015-11-19 961 $2.84 157,217 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.84 to $2.93, inclusive. The reporting person undertakes to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1).
  2. Includes 9,177 shares acquired under the InfuSystem Holdings, Inc. Employee Stock Purchase Plan.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.83 to $2.84, inclusive. The reporting person undertakes to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3).